Trial · NCT04570085
Registered outcomes24
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 24
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Changes in NTB scores | 30 weeks after randomization | difference between randomized value and value after 30 weeks of treatment |
| Secondary | Caffeine treatment effect on MMSE score | 30 weeks after randomization | difference between randomized value and value after 30 weeks of treatment on MMSE score |
| Secondary | Caffeine treatment effect on NTB subscores | 30 weeks after randomization | difference between randomized value and value after 30 weeks of treatment on NTB subscores |
| Secondary | Caffeine treatment effect on TAP scores | 30 weeks after randomization | difference between randomized value and value after 30 weeks of treatment on TAP scores |
| Secondary | Caffeine treatment effect on Epworth score | 30 weeks after randomization | difference between randomized value and value after 30 weeks of treatment on Epworth score |
| Secondary | Caffeine treatment effect on DAD-6 score | 30 weeks after randomization | difference between randomized value and value after 30 weeks of treatment on DAD-6 score |
| Secondary | Caffeine treatment effect on QoL-AD score | 30 weeks after randomization | difference between randomized value and value after 30 weeks of treatment on QoL-AD score |
| Secondary | Caffeine treatment effect on CGIC score | 30 weeks after randomization | difference between randomized value and value after 30 weeks of treatment on CGIC score |
| Secondary | Caffeine treatment effect on Zarit score | 30 weeks after randomization | difference between randomized value and value after 30 weeks of treatment on Zarit score |
| Secondary | persistent effect of caffeine treatment on MMSE score after a 6 weeks wash out period | 36 weeks after randomization | difference between value after 30 weeks of treatment and value after a 6 weeks wash out period (from Week 30 to Week 36) on MMSE score |
| Secondary | persistent effect of caffeine treatment on NTB subscores after a 6 weeks wash out period | 36 weeks after randomization | difference between value after 30 weeks of treatment and value after a 6 weeks wash out period (from Week 30 to Week 36) on NTB subscores |
| Secondary | persistent effect of caffeine treatment on TAP scores after a 6 weeks wash out period | 36 weeks after randomization | difference between value after 30 weeks of treatment and value after a 6 weeks wash out period (from Week 30 to Week 36) on TAP scores |
| Secondary | persistent effect of caffeine treatment on Epworth score after a 6 weeks wash out period | 36 weeks after randomization | difference between value after 30 weeks of treatment and value after a 6 weeks wash out period (from Week 30 to Week 36) on Epworth score |
| Secondary | persistent effect of caffeine treatment on DAD-6 score after a 6 weeks wash out period | 36 weeks after randomization | difference between value after 30 weeks of treatment and value after a 6 weeks wash out period (from Week 30 to Week 36) on DAD-6 score |
| Secondary | persistent effect of caffeine treatment on QoL-AD score after a 6 weeks wash out period | 36 weeks after randomization | difference between value after 30 weeks of treatment and value after a 6 weeks wash out period (from Week 30 to Week 36) on QoL-AD score |
| Secondary | persistent effect of caffeine treatment on Zarit score after a 6 weeks wash out period | 36 weeks after randomization | difference between value after 30 weeks of treatment and value after a 6 weeks wash out period (from Week 30 to Week 36) on Zarit score |
| Secondary | Caffeine effect heterogeneity: impact of AD treatment | 30 weeks after randomization | impact of AD treatment on caffeine effect |
| Secondary | Caffeine effect heterogeneity: impact of ApoE4 status | 30 weeks after randomization | impact of ApoE4 status on caffeine effect |
| Secondary | Caffeine effect heterogeneity: impact of caffeine metabolism speed | 30 weeks after randomization | impact of caffeine metabolism on caffeine effect |
| Secondary | Caffeine effect heterogeneity: impact of gender | 30 weeks after randomization | impact of gender on caffeine effect |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04570085/registered